Shares of Carvana Co. CVNA rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results.
Carvana reported second-quarter revenue of $3.41 billion, beating the consensus estimate of $3.244 billion, according to Benzinga Pro. The used car retailer reported quarterly earnings of 14 cents per share, beating analyst estimates for a loss of 12 cents per share.
Carvana shares jumped 13.4% to $151.12 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- FSD Pharma Inc. HUGE gained 55.2% to $0.1568 in pre-market trading after falling 7% on Wednesday.
- Immuneering Corporation IMRX gained 37.2% to $1.55 in pre-market trading after the company announced that IMM-1-104 was granted Fast Track designation from the FDA.
- CareDx, Inc CDNA rose 23% to $24.58 in today's pre-market trading after the company reported better-than-expected second-quarter financial results.
- MediaAlpha, Inc. MAX jumped 22.1% to $17.91 in pre-market trading after the company reported better-than-expected second-quarter financial results.
- Bone Biologics Corporation BBLG shares gained 20.8% to $2.61 in pre-market trading after gaining 23% on Wednesday.
- Olo Inc. OLO shares gained 19.1% to $5.69 in pre-market trading after the company reported better-than-expected second-quarter sales results.
- Sunnova Energy International Inc. NOVA shares rose 17.5% to $8.31 in pre-market trading following upbeat quarterly results.
- Kaixin Holdings KXIN shares gained 17.5% to $0.1308 in pre-market trading after the company announced it received a non-compliance notification from the Nasdaq.
- Rush Street Interactive, Inc. (NYSE RSI) shares rose 16.8% to $11.69 in pre-market trading after the company reported better-than-expected second-quarter earnings and raised FY24 revenue forecast.
Losers
- ALX Oncology Holdings Inc. ALXO shares dipped 25.8% to $3.56 in pre-market trading. The company announced it will host an investor call and webcast to share topline data results from the Phase 2 ASPEN-06 clinical trial evaluating evorpacept for the treatment of advanced HER2-positive gastric cancer.
- noco-noco Inc. NCNC shares fell 21.9% to $0.2240 in pre-market trading after jumping 88% on Wednesday.
- Alphatec Holdings, Inc. ATEC shares declined 18.9% to $8.19 in pre-market trading after the company reported second-quarter results.
- Udemy, Inc. UDMY fell 16.7% to $7.70 pre-market trading after the company reported mixed second-quarter financial results.
- Teladoc Health, Inc. TDOC shares declined 16.3% to $7.89 in pre-market trading following weak quarterly sales results.
- Tenable Holdings, Inc. TENB shares fell 14% to $39.51 in pre-market trading after the company reported second-quarter financial results.
- Standard Biotools Inc LAB dipped 12.9% to $1.95 in pre-market trading after the company posted weak second-quarter results.
- Confluent, Inc. CFLT shares declined 11.1% to $22.24 in pre-market trading after the company reported second-quarter financial results and issued third-quarter EPS guidance below estimates.
- Arm Holdings plc ARM shares fell 9.6% to $130.28 in pre-market trading following weak second-quarter guidance.
- Western Digital Corporation WDC fell 6.3% to $ 62.81 in today's pre-market trading after the company reported its fourth-quarter financial results.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.